California Public Employees Retirement System Igm Biosciences, Inc. Transaction History

California Public Employees Retirement System

$135 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$57.98 - $96.6 $834,912 - $1.39 Million	-14,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$71.56 - $121.23 $135,248 - $229,124	-1,890 Reduced 11.6%	14,400 $1.1 Million
Q4 2020 Feb 02, 2021	SELL	$47.41 - $115.03 $14,222 - $34,509	-300 Reduced 1.81%	16,290 $1.44 Million
Q3 2020 Nov 05, 2020	BUY	$43.0 - $84.01 $36,335 - $70,988	845 Added 5.37%	16,590 $1.23 Million
Q2 2020 Aug 12, 2020	SELL	$51.3 - $75.21 $545,678 - $800,008	-10,637 Reduced 40.32%	15,745 $1.15 Million
Q1 2020 May 12, 2020	BUY	$31.51 - $73.75 $217,576 - $509,243	6,905 Added 35.45%	26,382 $1.48 Million
Q4 2019 Jan 27, 2020	BUY	$17.25 - $49.51 $335,978 - $964,306	19,477 New	19,477 $743,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$70.6 Million
0.37% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.08M
Shares

$70.3 Million
0.0% of portfolio
Artal Group S.A. Luxembourg, N4

3.33M
Shares

$57.5 Million
1.45% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$53 Million
1.38% of portfolio
Goldman Sachs Group Inc New York, NY

1.33M
Shares

$23 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account